-
ZTE, Samsung now awaiting four court rulings after recent trials: considerable risk of knockout punches; Samsung already trying to avoid costs in U.S.
Read more: ZTE, Samsung now awaiting four court rulings after recent trials: considerable risk of knockout punches; Samsung already trying to avoid costs in U.S.Four ZTE-Samsung cases are under advisement in four different courts in three different countries. Two of them could get Samsung into trouble and the other two may not go well either.
-
Here’s what’s REALLY going on in the ZTE-Samsung dispute: why a Samsung case is dead in the water and what hurdles ZTE must overcome today
Read more: Here’s what’s REALLY going on in the ZTE-Samsung dispute: why a Samsung case is dead in the water and what hurdles ZTE must overcome todayThe ZTE-Samsung licensing dispute draws a lot of interest. Other publications have recently reported, but here we have additional information for you on the UPC Mannheim LD part of the dispute (partly free, partly premium).
-
UPC Dusseldorf LD finds Beko and Arçelik’s slowness to declare willingness — but not absence of Dolby pledge —dispositive of FRAND defense
Read more: UPC Dusseldorf LD finds Beko and Arçelik’s slowness to declare willingness — but not absence of Dolby pledge —dispositive of FRAND defenseFRAND case law keeps evolving at the UPC as different cases present different fact patterns.
-
Edwards Lifesciences defeats NPE in Delaware: first non-infringement, now invalidity, but same root cause in written description
Read more: Edwards Lifesciences defeats NPE in Delaware: first non-infringement, now invalidity, but same root cause in written descriptionEdwards Lifesciences made UPC history as a plaintiff. In the U.S. Edwards is proving its defensive resilience against an NPE.
-
Colombia pushes for compulsory licensing of U.S. pharma company’s patents
Read more: Colombia pushes for compulsory licensing of U.S. pharma company’s patentsColombia’s Health Minister has revived a previous administration’s investigation into four of U.S. pharma company Gilead’s patents at the core of Hepatitis-C treatment, issuing a public interest declaration to make the licensing of such patents compulsory.
-
UPC CoA stresses duty of full and frank disclosure when inspections are sought ex parte; denies ECJ referral, especially regarding UPCA and RoP
Read more: UPC CoA stresses duty of full and frank disclosure when inspections are sought ex parte; denies ECJ referral, especially regarding UPCA and RoPAnother appellate opinion from the UPC shows that the referral of certain questions of EU law in Dyson v. Dreame was an exception.
-
HMD files complaint accusing Federal Court of Justice of Germany of violating constitutional rights in ongoing VoiceAge EVS case
Read more: HMD files complaint accusing Federal Court of Justice of Germany of violating constitutional rights in ongoing VoiceAge EVS caseIn a constitutional complaint filed in the Federal Constitutional Court of Germany, HMD has alleged that the Federal Court of Justice of Germany’s refusal to refer “essential questions” of EU law to the European Court of Justice constitutes a “violation of its constitutional right to the lawful judge”.
-
Trumpf Laser wins second UPC injunction against rival IPG Laser: Dusseldorf LD ruling
Read more: Trumpf Laser wins second UPC injunction against rival IPG Laser: Dusseldorf LD rulingTrumpf Laser has won a second UPC case against IPG Laser, one of its two main rivals in the market for high-performance laser equipment for industrial applications. After the Mannheim LD, the Dusseldorf LD has also granted an injunction.
Follow Us
Latest Articles
- Eyeing the AI data center boom, Via Licensing Alliance unveils new NAND pool, issues call for patents
- Ibex sues Disney and Snap in Brazil as streaming patent disputes escalate
- Brazilian court lifts ZTE’s 5G injunction against Samsung as expert rejects infringement and essentiality claims
- Podcast: interview with Dr. Peter Georg Picht, SEP and competition law expert
- Geely takes Avanci license: combination of three near-simultaneous events leaves no room for reasonable doubt